Experts has a new look! Let us know what you think of the updates.

Provide feedback
Home
Scholarly Works
Hypocalcemia Risk of Denosumab Across the Spectrum...
Journal article

Hypocalcemia Risk of Denosumab Across the Spectrum of Kidney Disease: A Population‐Based Cohort Study

Abstract

Denosumab can be used in patients with chronic kidney disease (CKD) but has been linked with cases of severe hypocalcemia. The incidence of and risk factors for hypocalcemia after denosumab use are not well established. Using linked health care databases at ICES, we conducted a population-based cohort study of adults >65 years old with a new prescription for denosumab or a bisphosphonate between 2012 and 2020. We assessed incidence of …

Authors

Cowan A; Jeyakumar N; McArthur E; Fleet JL; Kanagalingam T; Karp I; Khan T; Muanda FT; Nash DM; Silver SA

Journal

Journal of Bone and Mineral Research, Vol. 38, No. 5, pp. 650–658

Publisher

Oxford University Press (OUP)

Publication Date

December 1, 2020

DOI

10.1002/jbmr.4804

ISSN

0884-0431